Previous Close | 4.120 |
Open | 4.090 |
Bid | 4.130 x N/A |
Ask | 4.180 x N/A |
Day's Range | 4.030 - 4.190 |
52 Week Range | 2.160 - 8.350 |
Volume | |
Avg. Volume | 2,382,141 |
Market Cap | 2.746B |
Beta (5Y Monthly) | 0.57 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.400 |
Earnings Date | Aug 23, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.81 |
Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its wholly-owned subsidiary, Achieva Medical Limited ("Achieva Medical"), entered into an exclusive distribution agreement with Jiangsu NowYon Medical Limited ("NowYon Medical"). The agreement marks a significant milestone in the expansion of Peijia Medical's Neurointerventional Business in the Greater China region.
Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced financial results for the six months ended June 30, 2024 ("the period") on August 23, 2024.